Stock Ratings / Health Care / AMRX / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Amneal Pharmaceuticals Inc. (AMRX) 12-Month Stock Forecast & Price Target Cone

$21.35 +0.99% NASDAQ • Public Delayed / 60s Snapshot

Amneal Pharmaceuticals Inc. (AMRX) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (65/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+146.4% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.

ROARABLE D+ • SELL / AVOID Cap $7.44B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw C- · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE+3.1% Base Target

WHALE OPTIONS TUG-OF-WAR:57% Call Buyers ($2.6M)

43% PutsMax Pain: $21.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your AMRX Position Size: $10,000

Shares at $21.35: 468.4 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $17.18

$8,047

$-1,953 (-19.5%)

12M Consensus BaseTarget $22.02

$10,314

+$314 (+3.1%)

12M Bull Case BreakoutTarget $25.98

$12,169

+$2,169 (+21.7%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$23	74%	A
Goldman SachsSector Coverage Lead	BUY	$24	69%	B
JP MorganUS Large-Cap Research	HOLD	$20	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Forensic Quant Desk

Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring AMRX)

✓Live walkthrough of AMRX's RQD Radar, SEC cash-conversion gap & downside levels
✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
✓Includes instant 24/7 email alert whenever any of your stocks flip to Red

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

AMRX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +67.13%📐 HORIZONTAL RANGE

2026-10-30O $21.51H $21.68L $21.27C $21.51VOL 2.77M

RES: $22.67SUP: $16.63SMA50: $19.12SMA200: $15.74

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

AMRX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 AMRX Butterfly Map → + Track AMRX →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

48.0%/yr Implied 5Y Growth

vs. +8.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on AMRX today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for AMRX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for AMRX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

AMRX Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is AMRX's 12-month stock price target?

Amneal Pharmaceuticals Inc. (AMRX) carries a 12-month consensus base price target of $22.02 (+3.1% from $21.35), with a bull-case target of $25.98 and a bear-case floor of $17.18.

Is AMRX stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates AMRX D+ (Sell — SELL) with an RQD Confidence score of 65/100.

Direct Sub-Reports: AMRX RQD Cockpit AMRX 12M Forecast AMRX Earnings & Move AMRX Dividends & DRIP AMRX Insiders & 13F AMRX Whale Options AMRX Profit Sankey AMRX News & Why